Ophthalmic drugs strategic business report 2023-2030: demand for otc eye medications, and increasing global incidence of eye diseases like glaucoma and amd bolsters the $56 billion market

Dublin, aug. 16, 2024 (globe newswire) -- the "ophthalmic drugs - global strategic business report" report has been added to researchandmarkets.com's offering. the global market for ophthalmic drugs is estimated at us$36.7 billion in 2023 and is projected to reach us$56.1 billion by 2030, growing at a cagr of 6.2% from 2023 to 2030. this comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. the growth in the ophthalmic drugs market is driven by several factors, including the aging global population and increasing prevalence of ocular diseases. technological advancements in drug delivery systems that enhance drug bioavailability and patient compliance are also significant contributors to market growth.
AMD Ratings Summary
AMD Quant Ranking